NO782707L - Fremgangsmaate for fremstilling av nye 2-pyridyl- og 2-pyrimidylaminobenzoesyrer - Google Patents

Fremgangsmaate for fremstilling av nye 2-pyridyl- og 2-pyrimidylaminobenzoesyrer

Info

Publication number
NO782707L
NO782707L NO782707A NO782707A NO782707L NO 782707 L NO782707 L NO 782707L NO 782707 A NO782707 A NO 782707A NO 782707 A NO782707 A NO 782707A NO 782707 L NO782707 L NO 782707L
Authority
NO
Norway
Prior art keywords
pyrimidylaminobenzoic
pyridyl
acids
procedure
preparation
Prior art date
Application number
NO782707A
Other languages
English (en)
Other versions
NO152605B (no
NO152605C (no
Inventor
Kurt Schromm
Anton Mentrup
Ernst-Otto Renth
Armin Fuegner
Volker Jacobi
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of NO782707L publication Critical patent/NO782707L/no
Publication of NO152605B publication Critical patent/NO152605B/no
Publication of NO152605C publication Critical patent/NO152605C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Medicinal Preparation (AREA)
NO782707A 1977-08-10 1978-08-09 Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-pyridyl- og 2-pyrimidylaminobenzoesyrer NO152605C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772735919 DE2735919A1 (de) 1977-08-10 1977-08-10 Neue 2-pyridyl- und 2-pyrimidylaminobenzoesaeuren

Publications (3)

Publication Number Publication Date
NO782707L true NO782707L (no) 1979-02-13
NO152605B NO152605B (no) 1985-07-15
NO152605C NO152605C (no) 1985-10-23

Family

ID=6016013

Family Applications (1)

Application Number Title Priority Date Filing Date
NO782707A NO152605C (no) 1977-08-10 1978-08-09 Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-pyridyl- og 2-pyrimidylaminobenzoesyrer

Country Status (32)

Country Link
US (1) US4241068A (no)
JP (1) JPS5430177A (no)
AT (1) AT370415B (no)
AU (1) AU520240B2 (no)
BE (1) BE869640A (no)
BG (1) BG30472A1 (no)
CA (1) CA1111037A (no)
CH (1) CH649289A5 (no)
CS (1) CS202506B2 (no)
DD (1) DD140351A5 (no)
DE (1) DE2735919A1 (no)
DK (1) DK148019C (no)
ES (5) ES472143A1 (no)
FI (1) FI71555C (no)
FR (1) FR2400017A1 (no)
GB (1) GB2002764B (no)
GR (1) GR65024B (no)
HU (1) HU179933B (no)
IE (1) IE47228B1 (no)
IT (1) IT1107960B (no)
LU (1) LU80094A1 (no)
MX (1) MX5672E (no)
NL (1) NL7808319A (no)
NO (1) NO152605C (no)
NZ (1) NZ188101A (no)
PH (1) PH19117A (no)
PL (2) PL115889B1 (no)
PT (1) PT68407A (no)
SE (1) SE444170B (no)
SU (2) SU735168A3 (no)
YU (1) YU40832B (no)
ZA (1) ZA784501B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3100516A1 (de) * 1981-01-10 1982-08-12 C.H. Boehringer Sohn, 6507 Ingelheim Pyridylaminobenzoesaeuren, ihre herstellung und verwendung
FR2533567A1 (fr) * 1982-09-23 1984-03-30 Ki I Farmakologii 2-(orthocarboxyphenylamino)-6h-pyrimido (2,1-b)-quinazolone-6 et ses derives, leur procede de preparation et leur application therapeutique
US4610991A (en) * 1983-04-18 1986-09-09 Sterling Drug Inc. Antihypertensive pyridylaminobenzamide compounds
JPS60100559A (ja) * 1983-11-05 1985-06-04 Morishita Seiyaku Kk ２−アニリノ−１，６−ジヒドロ−６−オキソ−５−ピリミジンカルボン酸誘導体，その製法及び該化合物を含有する抗アレルギ−剤
US4584379A (en) * 1985-01-22 1986-04-22 Merrell Dow Pharmaceuticals Inc. Isoquinoline thromboxane synthetase inhibitors
EP0219308B1 (en) * 1985-10-16 1991-10-23 Merck Frosst Canada Inc. 2-substituted quinolines
GB9615950D0 (en) * 1996-07-30 1996-09-11 Univ Warwick Variable reluctance machines
US6022884A (en) 1997-11-07 2000-02-08 Amgen Inc. Substituted pyridine compounds and methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1064259A (en) * 1963-12-19 1967-04-05 Union Pharma Scient Appl New derivatives of 2-anilino-nicotinic acid and process for their preparation
GB1162287A (en) * 1967-11-07 1969-08-20 Union Pharma Scient Appl New Salts of 2-Anilino-Nicotinic Acids
GB1264798A (no) * 1968-07-10 1972-02-23
ES416847A1 (es) * 1973-07-12 1976-03-01 Hermes Sa Lab Procedimiento para la obtencion de derivados del acido ni- cotinico.

Also Published As

Publication number Publication date
IT7850642A0 (it) 1978-08-08
FI71555B (fi) 1986-10-10
AU3877278A (en) 1980-02-14
ES480623A1 (es) 1980-01-01
SU886743A3 (ru) 1981-11-30
FI71555C (fi) 1987-01-19
IE781618L (en) 1979-02-10
AU520240B2 (en) 1982-01-21
PL115778B1 (en) 1981-04-30
AT370415B (de) 1983-03-25
ES480622A1 (es) 1980-01-01
BE869640A (fr) 1979-02-09
DD140351A5 (de) 1980-02-27
MX5672E (es) 1983-12-08
GB2002764B (en) 1982-08-04
IT1107960B (it) 1985-12-02
CA1111037A (en) 1981-10-20
DE2735919A1 (de) 1979-02-22
NO152605B (no) 1985-07-15
DK351978A (da) 1979-02-11
YU191678A (en) 1983-01-21
IE47228B1 (en) 1984-01-25
ATA549278A (de) 1982-08-15
ES472143A1 (es) 1979-03-16
GR65024B (en) 1980-06-16
SE7808530L (sv) 1979-02-11
SE444170B (sv) 1986-03-24
PL115889B1 (en) 1981-05-30
DK148019B (da) 1985-02-04
ES475456A1 (es) 1979-05-01
DK148019C (da) 1985-07-01
PH19117A (en) 1986-01-06
LU80094A1 (de) 1979-09-07
HU179933B (en) 1983-01-28
JPS6231704B2 (no) 1987-07-09
NO152605C (no) 1985-10-23
JPS5430177A (en) 1979-03-06
FI782039A7 (fi) 1979-02-11
CS202506B2 (en) 1981-01-30
FR2400017A1 (fr) 1979-03-09
PT68407A (de) 1978-09-01
US4241068A (en) 1980-12-23
YU40832B (en) 1986-06-30
NZ188101A (en) 1981-01-23
BG30472A1 (en) 1981-06-15
DE2735919C2 (no) 1988-10-27
PL208942A1 (no) 1979-12-03
GB2002764A (en) 1979-02-28
NL7808319A (nl) 1979-02-13
CH649289A5 (de) 1985-05-15
FR2400017B1 (no) 1983-03-11
SU735168A3 (ru) 1980-05-15
ZA784501B (en) 1980-04-30
ES475457A1 (es) 1979-11-16

Similar Documents

Publication Publication Date Title
NO145342C (no) Fremgangsmaate til fremstilling av nye fosfoglykolipid- og glykopeptidantibiotika
NO146431C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk virksomme arylsulfinylacetohydroksamsyrer
SE423994B (sv) Forfarande for framstellning av terapentiskt verksamma derivat av prolin och pipekolinsyra
SE7801428L (sv) Forfarande for framstellning av cefemkarbonsyror
SE430161B (sv) Forfarande for framstellning av heteroarylbensoxepin-ettiksyror och estrar derav
NO801046L (no) Penem-3-karboksylsyrederivater og fremgangsmaate til fremstilling av samme
SE7700489L (sv) Forfarande for framstellning av hypolipidemiska p-bensylaminobensoesyror och derivat derav
SE7804711L (sv) Forfarande for framstellning av fenolformaldehydskum och dervid framstellda produkter
NO782707L (no) Fremgangsmaate for fremstilling av nye 2-pyridyl- og 2-pyrimidylaminobenzoesyrer
SE7807055L (sv) Keramiskt alster och forfarande for tillverkning av detsamma
SE7803035L (sv) Forfarande for framstellning av tienopyridinderivat
SE7800933L (sv) Forfarande for framstellning av 3-metylpyridin
NO784382L (no) Fremgangsmaate for fremstilling av tiazoldin-derivater
SE7613839L (sv) Forfarande for framstellning av 2(1h)-kinazolinonderivat
NO782069L (no) Fremgangsmaate til fremstilling av nye nitrosourinstoff-derivater
SE7802024L (sv) Forfarande for framstellning av pyrrolokinoxalinoner och pyrrolobensodiazepinoner
SE7800932L (sv) Forfarande for framstellning av 2-metylpyridin och 3-metylpyridin
SE7605518L (sv) Forfarande for framstellning av 3,5-bisoxygenerade 2-(omega-halogen-3-oxygenerad-l-alkenyl)cyklopentan-l-heptansyror och derivat derav
SE7604669L (sv) Forfarande for framstellning av estrar av tiokarbamidsyror
SE7809202L (sv) Forfarande for framstellning av 2-klorsulfinylazetidin-4-oner
SE7804856L (sv) Forfarande vid framstellning av sampolymerisat av maleinsyraanhydrid och vinyltrialkoxisilaner
SE417086B (sv) Forfarande for framstellning av 2-etylindan och 2-isopropylindan
SE7604940L (sv) Forfarande for framstellning av sulfamylbensoesyror
NO149774C (no) Fremgangsmaate for fremstilling av et azetidinon
SE7805324L (sv) Forfarande for framstellning av 3-bromftalid